

06 Nov 2025
// BUSINESS WIRE
https://www.businesswire.com/news/home/20251106843166/en/Travere-Therapeutics-Announces-Late-Breaking-Data-from-Phase-3-DUPLEX-Study-of-FILSPARI-in-FSGS-Presented-at-the-American-Society-of-Nephrology-ASN-Kidney-Week-2025

04 Nov 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219539

01 Aug 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219840

19 Feb 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-19-2025-25389.pdf

06 Sep 2024
// BUSINESSWIRE

04 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/04/2940408/0/en/Context-Therapeutics-Appoints-Dr-Karen-Smith-and-Dr-Luke-Walker-to-Board-of-Directors.html